Lumasiran Sodium
Lumasiran Sodium, sold under the brand name Oxlumo, is a medication for the treatment of primary hyperoxaluria type 1 (PH1). Reference standards of Lumasiran Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Lumasiran Sodium - API Standards
[catalogue_number] => PA 12 1890000
[category_ids] => ,76,78,70,82,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => 1834612-06-4
[pslug] => 1834612-06-4-lumasiran-sodium-api-pa121890000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Lumasiran Sodium - API Standards